<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T23:45:04Z</responseDate>
  <request identifier="oai:figshare.com:article/33966923" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33966923</identifier>
        <datestamp>2026-09-22T17:25:27Z</datestamp>
        <setSpec>category_21</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_931</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Risk of bias of quantitative descriptive studies (mixed methods appraisal tool category 4).&lt;/p&gt;</dc:title>
          <dc:creator>Rocco Sheldon (24549748)</dc:creator>
          <dc:creator>Morya Wadodkar (24549751)</dc:creator>
          <dc:creator>Andrew Gan (24549754)</dc:creator>
          <dc:creator>Rachael Yip (25091168)</dc:creator>
          <dc:creator>Yimeng Zhang (283704)</dc:creator>
          <dc:creator>Jyoti Baharani (3584696)</dc:creator>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Information Systems not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>small sample sizes</dc:subject>
          <dc:subject>primary outcomes due</dc:subject>
          <dc:subject>one study reported</dc:subject>
          <dc:subject>large language models</dc:subject>
          <dc:subject>information fidelity ranging</dc:subject>
          <dc:subject>grade appraisal tool</dc:subject>
          <dc:subject>effectiveness remains fragmented</dc:subject>
          <dc:subject>drafting time compared</dc:subject>
          <dc:subject>1 november 2025</dc:subject>
          <dc:subject>findings regarding readability</dc:subject>
          <dc:subject>tactless patient descriptions</dc:subject>
          <dc:subject>authored control group</dc:subject>
          <dc:subject>outpatient clinic letters</dc:subject>
          <dc:subject>five using synthetic</dc:subject>
          <dc:subject>concerns regarding accuracy</dc:subject>
          <dc:subject>world clinic data</dc:subject>
          <dc:subject>providing insufficient evidence</dc:subject>
          <dc:subject>assessed quality using</dc:subject>
          <dc:subject>limiting patient comprehension</dc:subject>
          <dc:subject>studies evaluating ai</dc:subject>
          <dc:subject>world patient</dc:subject>
          <dc:subject>authored letters</dc:subject>
          <dc:subject>evidence regarding</dc:subject>
          <dc:subject>certainty using</dc:subject>
          <dc:subject>measured patient</dc:subject>
          <dc:subject>five databases</dc:subject>
          <dc:subject>extracted data</dc:subject>
          <dc:subject>clinical accuracy</dc:subject>
          <dc:subject>simplified letters</dc:subject>
          <dc:subject>two studies</dc:subject>
          <dc:subject>studies relied</dc:subject>
          <dc:subject>seven studies</dc:subject>
          <dc:subject>widespread adoption</dc:subject>
          <dc:subject>systematic review</dc:subject>
          <dc:subject>subjective measures</dc:subject>
          <dc:subject>scalable tools</dc:subject>
          <dc:subject>prospero registration</dc:subject>
          <dc:subject>overall certainty</dc:subject>
          <dc:subject>mmat ),</dc:subject>
          <dc:subject>methodological limitations</dc:subject>
          <dc:subject>low across</dc:subject>
          <dc:subject>improvement settings</dc:subject>
          <dc:subject>hypothetical scenarios</dc:subject>
          <dc:subject>generalisability remain</dc:subject>
          <dc:subject>fold reduction</dc:subject>
          <dc:subject>clinical communication</dc:subject>
          <dc:subject>centred research</dc:subject>
          <dc:subject>artificial intelligence</dc:subject>
          <dc:description>&lt;p&gt;Risk of bias of quantitative descriptive studies (mixed methods appraisal tool category 4).&lt;/p&gt;</dc:description>
          <dc:date>2026-09-22T17:25:16Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pdig.0001745.t003</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Risk_of_bias_of_quantitative_descriptive_studies_mixed_methods_appraisal_tool_category_4_p_/33966923</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
